ESC 365 - Safety and efficacy of single vs. dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation: a propensity matched analysis from the ITER registry

ESC Premium Access

Safety and efficacy of single vs. dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation: a propensity matched analysis from the ITER registry

Session: Transcatheter aortic valves: the evidence is growing

Topic: Aortic valve disease

Speaker: Doctor M. Bianco (Orbassano, IT)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Matteo Bianco

San Luigi Gonzaga University Hospital, Orbassano (Italy)

1 presentation

0 follower

8 more presentations in this session

Transcatheter aortic valve implantation in patients with advanced chronic kidney disease: futility or reliability?

Speaker: Doctor F. Conrotto (Turin, IT)

Multivariate Predictors for Adverse Long Term Outcome after Trancatheter Aortic Valve Implantation

Speaker: Mr A. Berkowitsch (Bad Nauheim, DE)

Comparison of transcatheter aortic valve implantation versus surgical aortic valve replacement and medical treatment: A systematic review and meta-analysis

Speaker: Assistant Professor M. Noutsias (Neuruppin, DE)

Transcatheter aortic valve implantation in high-risk patients with severely stenotic bicuspid versus tricuspid aortic valves

5-year follow-up after transcatheter aortic valve implantation (TAVI) in severe symptomatic aortic stenosis: results from the German TAVI registry

Speaker: Professor R. Zahn (Ludwigshafen, DE)

Access the full session

Transcatheter aortic valves: the evidence is growing

Speakers: Doctor M. Bianco, Doctor F. Conrotto, Mr A. Berkowitsch, Assistant Professor M. Noutsias, Professor R. Zahn

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources